Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION
25 mai 2021 04h22 HE
|
Hofseth Biocare ASA
Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA («HBC») has today purchased 50,000 shares in HBC at an average price of NOK 7.7295 per share. As a...
Hofseth Biocare ASA: FIRST QUARTER 2021 FINANCIAL REPORT
21 mai 2021 02h44 HE
|
Hofseth Biocare ASA
HBC had net sales revenues of NOK 16.8m (10.4m) in the first quarter and gross operating revenues of NOK 16.8m (18.5m). Gross revenues in first quarter 2020 included NOK 8.2m in insurance claim...
Hofseth Biocare ASA: GLOBAL INNOVATION PARTNERSHIP WITH CATALENT TO DEVELOP DELAYED-RELEASE FORMULATION OF OMEGO FISH OIL
12 mai 2021 02h45 HE
|
Hofseth Biocare ASA
ÅLESUND, NORWAY – May 12, 2021 — Hofseth BioCare ASA (HBC), a Norwegian biotech company that develops high-value ingredients and finished products, today announced that it has begun a global...
Hofseth Biocare ASA: COMPLETED ANNUAL GENERAL MEETING
23 avr. 2021 08h03 HE
|
Hofseth Biocare ASA
The AGM in Hofseth BioCare ASA was held in Havnegata 11, Ålesund today on Friday 23 April 2021. All the matters were decided according to the proposals in the notice. Please find the minutes from the...
Hofseth Biocare ASA: IMCD AND HBC EXTEND INTERNATIONAL AGREEMENT TO INCLUDE EUROPE
15 avr. 2021 02h00 HE
|
Hofseth Biocare ASA
European Biotech and consumer health company HBC has confirmed plans to extend an exclusive distribution agreement for its marine branded products with leading speciality chemicals and ingredients...
Hofseth BioCare ASA: NOTICE OF ANNUAL GENERAL MEETING 2021
05 avr. 2021 17h33 HE
|
Hofseth Biocare ASA
The Annual General Meeting of Hofseth BioCare ASA will be held at the company's premises at Havnegata 11, 6005 Ålesund, on 23 April 2021 at 13:00 CET. All shareholders are encouraged to submit a...
Hofseth Biocare ASA: NESTLE-OWNED GARDEN OF LIFE TO LAUNCH NEW PRODUCTS WITH PROGO® IN US RETAIL & ONLINE MARKETS
31 mars 2021 02h45 HE
|
Hofseth Biocare ASA
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act This stock exchange notice follows previous references made in the...
Hofseth Biocare ASA: HBC Annual Report 2020 and ESG Report
19 mars 2021 03h14 HE
|
Hofseth Biocare ASA
Today, 19 March 2021, the Board of Directors approved the Annual Report for 2020. Please find the Annual Report 2020 in Norwegian and English, including the ESG Report (Chapter 5) attached. For...
Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION
05 févr. 2021 06h14 HE
|
Hofseth Biocare ASA
Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA (“HBC”), has today purchased 70,000 shares in HBC at an average price of NOK 9.294 per share. As a...
Hofseth Biocare ASA: FOURTH QUARTER 2020 FINANCIAL REPORT
05 févr. 2021 02h00 HE
|
Hofseth Biocare ASA
HBC had gross operating revenues of NOK 69.3m (67.8m) in 2020 and operating revenues of NOK 23.1m (11.1m) in the fourth quarter. Cost of Goods Sold (CoGS) amounted to NOK 16.7m (16.6m) in the quarter...